Mol Carcinog. 2005 Sep;44(1):42-50.

Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling.

Yin Y, Bai R, Russell RG, Beildeck ME, Xie Z, Kopelovich L, Glazer RI.

Source

Department of Oncology, and Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Abstract

Mouse mammary tumors arising during medroxyprogesterone-DMBA-mediated mammary carcinogenesis comprised three distinct phenotypes: adenocarcinoma, squamous cell carcinoma, and myoepithelial carcinoma. The molecular signature for each of the three tumor subsets was characterized by gene microarray analysis, and three distinct sets of gene expression profiles were obtained that were corroborated in part by quantitative RT-PCR and immunohistochemistry. These results suggest that this carcinogenesis and gene expression model will be useful for rapidly assessing the histopathological differences arising in mammary carcinogenesis and the effects of tumor promoting or chemoprevention agents.

Published 2005 Wiley-Liss, Inc.

PMID:: 15937957; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Molecular Biology Databases

Miscellaneous

Mouse Genome Informatics (MGI)

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Gene expression profiling during rat mammary carcinogenesis induced by 7,12-dimethylbenz[a]anthracene. [Int J Cancer. 2009]
Gene expression profiling during rat mammary carcinogenesis induced by 7,12-dimethylbenz[a]anthracene.
Souda M, Umekita Y, Abeyama K, Yoshida H. Int J Cancer. 2009 Sep 15; 125(6):1285-97.
Etiology-specific gene expression profiles in rat mammary carcinomas. [Cancer Res. 2002]
Etiology-specific gene expression profiles in rat mammary carcinomas.
Kuramoto T, Morimura K, Yamashita S, Okochi E, Watanabe N, Ohta T, Ohki M, Fukushima S, Sugimura T, Ushijima T. Cancer Res. 2002 Jul 1; 62(13):3592-7.
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. [Toxicol Pathol. 2005]
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors.
Currier N, Solomon SE, Demicco EG, Chang DL, Farago M, Ying H, Dominguez I, Sonenshein GE, Cardiff RD, Xiao ZX, et al. Toxicol Pathol. 2005; 33(6):726-37.
Review A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis. [J Mammary Gland Biol Neoplasia. 2009]
Review A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.
Stein T, Salomonis N, Nuyten DS, van de Vijver MJ, Gusterson BA. J Mammary Gland Biol Neoplasia. 2009 Jun; 14(2):99-116. Epub 2009 Apr 30.
Review Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis. [Ann N Y Acad Sci. 2005]
Review Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
Nesterova MV, Cho-Chung YS. Ann N Y Acad Sci. 2005 Nov; 1058:255-64.

See reviews... See all...

Cited by 8 PubMed Central articles

Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling. [Proc Natl Acad Sci U S A. 2011]
Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling.
Upadhyay G, Yin Y, Yuan H, Li X, Derynck R, Glazer RI. Proc Natl Acad Sci U S A. 2011 May 10; 108(19):7820-5. Epub 2011 Apr 25.
Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation. [PPAR Res. 2010]
Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation.
Pollock CB, Rodriguez O, Martin PL, Albanese C, Li X, Kopelovich L, Glazer RI. PPAR Res. 2010; 2010:571783. Epub 2010 Dec 27.
PPARδ activation acts cooperatively with 3-phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesis. [PLoS One. 2011]
PPARδ activation acts cooperatively with 3-phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesis.
Pollock CB, Yin Y, Yuan H, Zeng X, King S, Li X, Kopelovich L, Albanese C, Glazer RI. PLoS One. 2011 Jan 13; 6(1):e16215. Epub 2011 Jan 13.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tu...
Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling.
Mol Carcinog. 2005 Sep ;44(1):42-50.

PubMed
Novel prognostic immunohistochemical biomarker panel for estrogen receptor-posit...
Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.
J Clin Oncol. 2006 Jul 1 ;24(19):3039-47.

PubMed
Targeting the mammalian target of rapamycin (mTOR): a new approach to treating c...
Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer.
Br J Cancer. 2004 Oct 18 ;91(8):1420-4.

PubMed
Tumor development under angiogenic signaling: a dynamical theory of tumor growth...
Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy.
Cancer Res. 1999 Oct 1 ;59(19):4770-5.

PubMed
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for ad...
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
Cancer. 2003 Nov 1 ;98(9):1802-10.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Molecular Biology Databases

Miscellaneous

Libraries

Supplemental Content

Related citations

Cited by 8 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information